FdaApplication

BLA 761333

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAmgen Inc.
application_typeBLA
approval_date2024-05-28

Products (1)

ProductActive ingredientStrengthDosage form
BKEMVECULIZUMAB-AEEB300MG/30ML (10MG/ML)Injection

1 product